To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Migraleve is the brand name of a range of migraine-relief medications made by Pfizer.
There are two variants of Migraleve: Yellow and pink, which all contain the analgesic paracetomol and codeine. The yellow variant is designed to address the symptoms of headache and discomfort, whilst the pink variant also addresses symptoms of nausea and vomiting.
Additional recommended knowledge
The active ingredients of Migraleve Yellow are:
Other ingredients: magnesium stearate, colloidal anhydrous silica, stearic acid, pregelatinised maize starch, gelatin, hypromellose, macrogol, E104 (quinoline yellow), aluminium oxide, E171 (titanium dioxide) and E172 (iron oxide yellow).
The active ingredients of Migraleve Pink are:
Other ingredients: magnesium stearate, colloidal anhydrous silica, stearic acid, pregelatinised maize starch, gelatin, hypromellose, macrogol, E127 (erythrosine), aluminium oxide and E171 (titanium dioxide).
License and manufacture
The Product Licence Holder is: Pfizer Consumer Healthcare, Walton-on-the-Hill, Surrey, KT20 7NS 
The manufacturer is: Gödecke GmbH, Mooswaldallee 1, 79090, Freiburg, Germany.
Categories: Analgesics | Antiemetics
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Migraleve". A list of authors is available in Wikipedia.|